ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Oxford-Based Mirada Announces Partnership with RamSoft - Developer of the World's First Imaging EMR - to Expand Global Footprint

RamSoft Inc.

 

OXFORD, UK – TheNewswire – July 25, 2023

Mirada Medical, a global leader in advanced visualization software based in Oxford, announced today the expansion of their embedded partnership program to include RamSoft, developer of the world's first Imaging EMR, OmegaAI.

Mirada Medical specializes in advanced visualization applications that help healthcare professionals use medical images more effectively and efficiently to improve cancer care. Its technology is available in more than 2,000 hospitals worldwide. Mirada’s partnership with RamSoft is part of the company’s global initiative to expand access to Mirada’s pioneering technology and accelerate cancer diagnosis and treatment for patients across the globe. 

 

The partnership with Mirada signifies the incorporation of RamSoft customers to the thousands of global healthcare professionals who currently utilize multimodality and image registration tools geared to provide users with an incomparable user experience and access to more imaging data via an advanced intuitive interface. The cloud-native, serverless OmegaAI platform will now host both Mirada RTx and XD, endowing clinicians with the complementary tools they need when they need them. 

 

“This partnership with Mirada Medical represents a new chapter for RamSoft and its mission to help healthcare providers worldwide deliver faster, empowered care,” shared RamSoft CEO and Co-Founder, Vijay Ramanathan, “Bringing together the innovation potential of these two companies and the tremendous impact this partnership will have in propelling universal access to imaging and saving patient lives is quite momentous. RamSoft is proud to play a collaborative role in Mirada Medical’s exciting, far-reaching global initiative.”

 

Jon Devries, CEO of Mirada Medical, added: “Faced with limited resources, clinics and hospitals are looking to technology to streamline a patient’s clinical journey. We are excited to have RamSoft as part of our embedded partner program to bring Mirada’s technology to more patients. Together we will support healthcare clinics globally to standardize high-quality reading, planning, and reporting for cancer patients while continuing to help RamSoft customers to provide faster empowered care to their patients. We are thrilled to be a part of the RamSoft portfolio of products and believe that this partnership will help healthcare professionals to accelerate cancer care. “

About Mirada Medical Ltd 

Mirada Medical is a leading international brand in medical imaging. The company develops advanced technology applications that help healthcare professionals use medical images more effectively and efficiently to improve and accelerate cancer care. Mirada’s products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, tumor board, and elsewhere in the clinic. Mirada’s advanced technology products are available throughout the world under its own brand, and on an OEM basis through a select number of the world’s leading healthcare companies. For more information on Mirada Medical, please visit: www.mirada-medical.com. 

 

About RamSoft 

RamSoft is a healthcare IT software provider of choice for organizations seeking to provide faster, empowered care. We leverage more than two decades of experience in developing innovative medical imaging workflow solutions, including the world’s first Imaging EMR, OmegaAI. Our products are trusted by healthcare organizations worldwide. To learn more about RamSoft: www.ramsoft.com. 

 

###

Mirada Medical

Email: marketing@mirada-medical.com

Website: www.mirada-medical.com

 

Copyright (c) 2023 TheNewswire - All rights reserved.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.